Fred K. Friedman

2.8k total citations
121 papers, 2.5k citations indexed

About

Fred K. Friedman is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Fred K. Friedman has authored 121 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Molecular Biology, 48 papers in Pharmacology and 37 papers in Oncology. Recurrent topics in Fred K. Friedman's work include Pharmacogenetics and Drug Metabolism (47 papers), Cancer-related Molecular Pathways (23 papers) and Monoclonal and Polyclonal Antibodies Research (15 papers). Fred K. Friedman is often cited by papers focused on Pharmacogenetics and Drug Metabolism (47 papers), Cancer-related Molecular Pathways (23 papers) and Monoclonal and Polyclonal Antibodies Research (15 papers). Fred K. Friedman collaborates with scholars based in United States, United Kingdom and India. Fred K. Friedman's co-authors include Matthew R. Pincus, Harry V. Gelboin, Richard C. Robinson, Aditya P. Koley, Renke Dai, Allen Markowitz, Paul W. Brandt‐Rauf, Sherman Beychok, Jeroen Buters and Robert E. Vestal and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Fred K. Friedman

120 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fred K. Friedman United States	27	1.3k	979	744	230	211	121	2.5k
Paul P. Tamburini United States	27	937 0.7×	662 0.7×	538 0.7×	176 0.8×	106 0.5×	48	2.1k
Ingela Jansson United States	23	851 0.6×	747 0.8×	326 0.4×	121 0.5×	89 0.4×	43	1.9k
Sergey A. Usanov Belarus	24	1.0k 0.8×	1.0k 1.1×	316 0.4×	186 0.8×	269 1.3×	137	2.6k
Linda M. Reik United States	22	845 0.6×	1.5k 1.5×	614 0.8×	93 0.4×	94 0.4×	28	2.6k
Thomas G. Consler United States	21	2.1k 1.6×	832 0.8×	2.0k 2.7×	149 0.6×	202 1.0×	29	4.7k
Suresh K. Balani United States	26	772 0.6×	639 0.7×	755 1.0×	428 1.9×	199 0.9×	69	2.6k
Alfin D. N. Vaz United States	26	1.1k 0.8×	1.0k 1.0×	513 0.7×	71 0.3×	196 0.9×	59	2.7k
Amin A. Nomeir United States	28	834 0.6×	483 0.5×	682 0.9×	94 0.4×	253 1.2×	111	2.7k
H V Gelboin United States	30	1.4k 1.1×	1.9k 1.9×	840 1.1×	116 0.5×	138 0.7×	58	3.6k
Iain Gardner United Kingdom	28	987 0.8×	765 0.8×	431 0.6×	135 0.6×	375 1.8×	94	2.9k

Countries citing papers authored by Fred K. Friedman

Since Specialization

Citations

This map shows the geographic impact of Fred K. Friedman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fred K. Friedman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fred K. Friedman more than expected).

Fields of papers citing papers by Fred K. Friedman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fred K. Friedman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fred K. Friedman. The network helps show where Fred K. Friedman may publish in the future.

Co-authorship network of co-authors of Fred K. Friedman

This figure shows the co-authorship network connecting the top 25 collaborators of Fred K. Friedman. A scholar is included among the top collaborators of Fred K. Friedman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fred K. Friedman. Fred K. Friedman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bowne, Wilbur B., Victor Adler, Paul W. Brandt‐Rauf, et al.. (2008). PNC-27 and PNC-28 anticancer peptides selectively kill cancer cells by pore formation dependent on the binding of these peptides to hdm2 in cancer cell membranes.. Cancer Research. 68. 1 indexed citations

Duncan, T. Michael, et al.. (2004). Comparison of Molecular Dynamics Averaged Structures for Complexes of Normal and Oncogenic ras-p21 with SOS Nucleotide Exchange Protein, Containing Computed Conformations for Three Crystallographically Undefined Domains, Suggests a Potential Role of These Domains in ras Signaling. The Protein Journal. 23(3). 217–228. 3 indexed citations

Hadjokas, Nicholas, Renke Dai, Fred K. Friedman, et al.. (2002). Arginine to lysine 108 substitution in recombinant CYP1A2 abolishes methoxyresorufin metabolism in lymphoblastoid cells. British Journal of Pharmacology. 136(3). 347–352. 16 indexed citations

Friedman, Fred K., et al.. (2002). Identification of the Site of Inhibition of Mitogenic Signaling by Oncogenic ras-p21 by a ras Effector Peptide. Journal of Protein Chemistry. 21(5). 367–370. 9 indexed citations

Zhai, Suoping, Renke Dai, Xiaoxiong Wei, Fred K. Friedman, & Robert E. Vestal. (1998). Inhibition of methoxyresorufin demethylase activity by flavonoids in human liver microsomes. Life Sciences. 63(8). PL119–PL123. 19 indexed citations

Chung, Denise, James Chen, Fred K. Friedman, et al.. (1997). Inhibition of Oncogenic and Activated Wild-Type ras-p21 Protein-Induced Oocyte Maturation by Peptides from the ras-Binding Domain of the raf-p74 Protein, Identified from Molecular Dynamics Calculations. Journal of Protein Chemistry. 16(6). 631–635. 21 indexed citations

Koley, Aditya P., Jeroen Buters, Richard C. Robinson, Allen Markowitz, & Fred K. Friedman. (1997). Differential Mechanisms of Cytochrome P450 Inhibition and Activation by α-Naphthoflavone. Journal of Biological Chemistry. 272(6). 3149–3152. 121 indexed citations

Chung, Denise, Victor Adler, Ze’ev A. Ronai, et al.. (1997). Selective inhibition of oncogenic ras- p21 in vivo by agents that block its interaction with jun -N-kinase (JNK) and jun proteins. Implications for the design of selective chemotherapeutic agents. Cancer Chemotherapy and Pharmacology. 41(1). 79–85. 26 indexed citations

Koley, Aditya P., Jeroen Buters, Richard C. Robinson, Allen Markowitz, & Fred K. Friedman. (1996). Interaction of Polycyclic Aromatic Hydrocarbons with Human Cytochrome P450 1A1: A CO Flash Photolysis Study. Archives of Biochemistry and Biophysics. 336(2). 261–267. 2 indexed citations

10.

Omata, Y., Robert Robinson, H V Gelboin, Matthew R. Pincus, & Fred K. Friedman. (1994). Specificity of the cytochrome P‐450 interaction with cytochromeb₅. FEBS Letters. 346(2-3). 241–245. 15 indexed citations

11.

Koley, Aditya P., Richard C. Robinson, Allen Markowitz, & Fred K. Friedman. (1994). Kinetics of CO Binding to Cytochromes P450 in the Endoplasmic Reticulum. Biochemistry. 33(9). 2484–2489. 14 indexed citations

12.

Dykes, Daryll C., et al.. (1993). Activated Conformations of theras-Gene-Encoded p21 Protein. 2. Comparison of the Computed and High-Resolution X-ray Crystallographic Structures of Gly-12 p21. Journal of Biomolecular Structure and Dynamics. 10(5). 905–918. 3 indexed citations

13.

Omata, Yoshiaki & Fred K. Friedman. (1992). The effect of dilauroyl‐l‐3‐phosphatidylcholine on the interaction between cytochrome P‐450 1A1 and benzo[a]pyrene. FEBS Letters. 309(3). 249–252. 3 indexed citations

14.

Dykes, Daryll C., et al.. (1992). Activated Conformations of the ras -gene-Encoded p21 Protein. 1. An Energy-Refined Structure for the Normal p21 Protein Complexed with GDP. Journal of Biomolecular Structure and Dynamics. 9(6). 1025–1044. 6 indexed citations

15.

Chung, Denise, Fred K. Friedman, Richard Robinson, et al.. (1992). Evidence that oocyte maturation induced by an oncogenic ras-p21 protein and insulin is mediated by overlapping yet distinct mechanisms. Experimental Cell Research. 203(2). 329–335. 24 indexed citations

16.

Omata, Yoshiaki & Fred K. Friedman. (1992). Cytochrome P 450-benzphetamine interactions in the endoplasmic reticulum: studies using a monoclonal antibody to P 450b. Biochemistry. 31(37). 8862–8867. 3 indexed citations

17.

Carubelli, Raoul, et al.. (1991). Prevention of 2-acetylaminofluorene-induced loss of nuclear envelope cytochrome P450 by the simultaneous administration of 3-methylcholanthrene. Biochemical Pharmacology. 41(9). 1331–1334. 2 indexed citations

18.

Robinson, Richard C., Robert Shorr, Angela Varrichio, et al.. (1989). Human Liver Cytochrome P-450 Related to a Rat Acetone-Inducible, Nitrosamine-Metabolizing Cytochrome P-450: Identification and Isolation. Pharmacology. 39(3). 137–144. 8 indexed citations

19.

Friedman, Fred K., Donna West, Paul M. Dewick, & Harry V. Gelboin. (1985). Specificity of Medicarpin and Related Isoflavonoids in Inhibition of Rat Hepatic Mixed Function Oxidase Activity. Pharmacology. 31(5). 289–293. 6 indexed citations

20.

Friedman, Fred K., Robert Robinson, Byeong Jun Song, et al.. (1985). Monoclonal antibody-directed determination of cytochrome P-450 types expressed in a human lymphoblastoid cell line.. Molecular Pharmacology. 27(6). 652–655. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact